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Purpose: Mutations in destrin (Dstn) cause corneal abnormalities in mice. A null mutation, Dstncorn1, results in corneal
epithelial  hyperproliferation,  inflammation,  and  neovascularization  in  the  A.BY  background  (A.BY  Dstncorn1).
Homozygosity for a point mutation, Dstncorn1–2J, results in mild thickening of the corneal epithelium but no corneal
neovascularization in a C57BL/6 (B6) background (B6 Dstncorn1–2J). The goal of this study was to determine whether
phenotypic differences are due to allelic differences between Dstncorn1 and Dstncorn1–2J, or are the result of genetic
background effects.
Methods: We generated two congenic (Cg) mouse lines, B6.Cg-Dstncorn1 and A.BY.Cg-Dstncorn1–2J, to compare to the
original A.BY Dstncorn1 and B6 Dstncorn1–2J lines. We performed immunohistochemistry to assay F-actin accumulation,
neovascularization, proliferation, and inflammation. By western blot analysis we tested the expression of serum response
factor (SRF), a known regulator of the Dstncorn1 phenotype.
Results: The Dstncorn1 mutation leads to neovascularization, hyperproliferation, and inflammation in the cornea of A.BY
Dstncorn1 as well as B6.Cg-Dstncorn1 mice. We did not observe significant corneal neovascularization or hyperproliferation
in either A.BY.Cg-Dstncorn1–2J or B6 Dstncorn1–2J mice. Actin accumulation, neovascularization, epithelial proliferation
and inflammation in B6.Cg-Dstncorn1 cornea are significantly reduced when compared to A.BY Dstncorn1cornea. SRF
changes are consistent in Dstncorn1 mutants, regardless of genetic background.
Conclusions: Differences in the abnormal phenotypes of Dstn mutants result from allelic differences between Dstncorn1
and Dstncorn1–2J . Moreover, phenotypes of Dstncorn1 mice are modified by genetic background, suggesting the existence
of genetic modifiers. Protein analysis suggests that a genetic modifier affects phenotypic severity functionally downstream
from or in a pathway independent from SRF. These data demonstrate that natural genetic variation affects phenotypic
severity in Dstncorn1 mice.
Mutations in the gene for the actin depolymerizing factor
destrin (DSTN), lead to abnormalities in the structure and
function  of  the  cornea  and  subsequent  blindness  in  mice
[1-3]. Since actin depolymerizing factors including DSTN
function to maintain a homeostatic ratio of actin in two forms,
filamentous actin (F-actin) and globular actin (G-actin) [4],
Dstn  mutant  mice  demonstrate  the  importance  of  actin
dynamics regulation to the proper structure and functions of
the cornea. We have previously reported both phenotypic and
gene expression differences between two mutations of the
Dstn  gene,  Dstncorn1  and  Dstncorn1–2J  [2,3].  The  Dstncorn1
mutation is characterized by deletion of a ~35 Kb region
containing the entire coding sequence for Dstn, while the
Dstncorn1–2J allele has been identified as a point mutation in
exon 3, resulting in a Proline to Serine amino acid change in
the actin binding domain [3]. Dstncorn1 was isolated and has
been  maintained  in  the  A.BY  genetic  background,  while
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Dstncorn1–2J  has  been  propagated  in  the  C57BL/6  (B6)
background.
There  are  four  major  classes  of  phenotypes  that
distinguish the two Dstn mutations. First, while both mutants
display abnormal levels of F-actin accumulation in the corneal
epithelium, consistent with the role of DSTN to depolymerize
F-actin, A.BY Dstncorn1 mice display extreme misregulation
of actin dynamics, leading to structural breakdown of the
corneal epithelium. B6 Dstncorn1–2J mice display mild F-actin
accumulation but maintain overall structural integrity of the
corneal epithelium [3]. Second, while A.BY Dstncorn1 mice
develop neovascularization into the cornea, B6 Dstncorn1–2J
cornea remain free of any abnormal vasculature. Third, the
A.BY  Dstncorn1  mutants  demonstrate  increased  epithelial
thickening due to proliferating cells throughout the corneal
epithelium when compared to B6 Dstncorn1–2J [1,3]. Fourth,
A.BY Dstncorn1 mutants displayed significant recruitment of
inflammatory cells to the corneal epithelium when compared
to B6 Dstncorn1–2J [5]. Since these mutations are on different
genetic backgrounds, it was impossible to deduce whether
phenotypic differences between Dstncorn1 and Dstncorn1–2J were
solely due to differences in mutant alleles, or if the mutants
are differentially affected because of genetic backgrounds.
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606To observe each mutation independently of background
effects, we used the original lines, A.BY Dstncorn1 and B6
Dstncorn1–2J, to create a pair of congenic (Cg) lines, B6.Cg-
Dstncorn1  and  A.BY.Cg-Dstncorn1–2J  .  By  comparing  A.BY
Dstncorn1 to A.BY.Cg-Dstncorn1–2J and B6 Dstncorn1–2J to B6.Cg-
Dstncorn1, we are able to assess the allelic differences between
the two mutants independent of genetic background effects.
Moreover, by comparing A.BY Dstncorn1 to B6.Cg-Dstncorn1
and A.BY.Cg-Dstncorn1-2J to B6 Dstncorn1-2J, we can observe the
effects  of  genetic  background  on  the  disease  phenotypes
attributed  to  different  types  of  mutations.  These  analyses
demonstrated  that  both  allelic  difference  and  genetic
background  affect  the  severity  of  corneal  abnormalities
caused by the Dstn mutation.
METHODS
Mouse  husbandry:  A.BY-H2b  H2-T18b/SnJ  (A.BY  WT),
C57BL/6J WT (B6 WT), A. BY-H2b H2T18b/SnJ-Dstncorn1/J
(A.BY Dstncorn1), and C57BL/6JSmn-Dstncorn1–2J (B6 Dstncorn1–
2J) mice were obtained from the Jackson Laboratory (Bar
Harbor, ME) and bred in an animal facility at the University
of  Wisconsin-Madison.  All  mouse  procedures  were
performed in accordance with the protocols approved by the
Animal  Care  and  Use  Committee  at  the  University  of
Wisconsin-Madison  and  conform  to  the  Association  for
Research in Vision and Ophthalmology (ARVO) statement
for the use of animals in ophthalmic and vision research.
Generation of congenic mouse lines: B6.Cg-Dstncorn1 mice
were generated by crossing A.BY Dstncorn1 mice to B6 WT
mice,  selecting  for  mice  carrying  a  Dstncorn1  allele,  and
backcrossing to B6 WT for 8 generations. Heterozygous mice
were intercrossed and progeny genotyped as homozygous for
the  Dstncorn1  mutation  were  used  for  analysis.  A.BY.Cg-
Dstncorn1-2J mice were generated by crossing B6 Dstncorn1–2J
mice  to  A.BY  WT  mice,  selecting  for  mice  carrying  a
Dstncorn1–2J  allele,  and  backcrossing  to  A.BY  WT  for  10
generations.  Heterozygous  mice  were  intercrossed  and
progeny  genotyped  as  homozygous  for  the  Dstncorn1–2J
mutation were used for analysis.
Genotyping:  All  mice  were  genotyped  using  polymerase
chain reaction (PCR). To genotype for Dstn+, primers mADF-
F31 (5′-GTC CCA TGA ATG TGA ATT GC-3′) and mADF-
R28 (5′-CCC TGG TGA CCT TTC CTT ATC-3′) were used
for amplification. To genotype for Dstncorn1, primers mADF-
F32 (5′-GCC ACA TCA TTA GCT TTT GAA G3′) and
mADF-R30 (5′-TGG CAC TCC TGC TGT CAC-3′) were
used for amplification. To genotype for Dstncorn1–2J, primers
mADF-F35 (5′TGG AGG GTG TGC TTT CTC TAC-3′) and
mADF-R32 (5′-CTA CGA AGA TAA TAA GGT GGG C-3′)
were used for amplification, followed by digestion of the PCR
product with the restriction enzyme BanI.
Immunohistochemistry: All mice were analyzed at postnatal
day  58  (P58),  unless  otherwise  indicated.
Immunohistochemistry on frozen sections was performed as
described previously [2]. Briefly, after removal, eyes were
fixed in paraformaldehyde and gradients of sucrose before
sectioning. Sections were blocked with phosphate-buffered
saline (PBS) with 0.5% Triton X and 2% normal donkey
serum before overnight incubation with primary antibodies.
Sections  were  then  rinsed  with  PBS,  incubated  with  a
secondary antibody, and stained with DAPI. The primary
antibodies  and  dilutions  used  for  the  analysis  were  Ki67
(1:100; Thermo Scientific, Fremont, CA), myeloperoxidase
(1:200;  R&D  Systems,  Minneapolis,  MN),  and  cluster  of
differentiation 45 (CD45; 1:100; BD Pharmigen, San Diego,
CA). Sections were incubated with Alexa Fluor 488 or 568
conjugated secondary antibody (1:400; Invitrogen, Carlsbad,
CA)  or  Alexa  Fluor  568  conjugated  phalloidin  (1:50;
Invitrogen) and were counterstained with 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI, 1:200; Sigma-Aldrich,
St. Louis, MO).
Immunohistochemistry on whole cornea was performed
as described previously [2]. Briefly, after removal of the eye,
corneas  were  removed  and  fixed  in  paraformaldehyde
overnight. Corneas were then rinsed in PBS and post-fixed in
100% acetone, followed by additional PBS rinses. Corneas
were blocked overnight in PBS with 0.8% Triton and 2%
normal donkey serum, followed with an overnight incubation
with the primary antibody in block solution. The primary
antibody  for  cluster  of  differentiation  31  (CD31;  BD
Pharmigen) was used at a dilution of 1:50. Corneas were
transferred  to  block  solution  containing  phalloidin  (1:50;
Invitrogen) and an Alexa Fluor 488 conjugated secondary
antibody (1:200; Invitrogen). Corneas were counterstained
with DAPI (1:200; Sigma-Aldrich).
Imaging:  Images  acquired  on  sections  and  whole  mount
cornea were captured on an Eclipse E600 microscope (Nikon,
Tokyo,  Japan)  using  a  SPOT  camera  (Spot  Diagnostics,
Sterling Heights, MI) or a Zeiss 510 confocal laser scanning
system and Axio Imager microscope using LSM 510 software
(release 4.2; Carl Zeiss MicroImaging, Thornwood, NY). For
images obtained of the surface of eye, mice were sacrificed
and immediately placed under the objective of a Zeiss Stemi
SV11 dissecting scope attached to a Nikon COOLPIX 995
digital camera (Nikon).
Western blotting: For each line, six corneas pooled from three
mice were homogenized in RIPA buffer (1× PBS with 1%
NP-40 and 0.1%SDS) containing a protease inhibitor cocktail.
Protein concentrations were determined using the Precision
Red  protein  assay  reagent  (Cytoskeleton,  Denver,  CO)
according to the manufacturer’s instructions. Equal amount of
protein were subjected to SDS–PAGE using 4%–12% Bis-tris
gels  and  antibodies  against  SRF  (1:1,000;  Santa  Cruz
Biotenchnology,  Santa  Cruz,  CA),  and  FMR1  (1:4,000;
Millipore, Billerica, MA). Blots were treated with horseradish
peroxidase  conjugated  secondary  antibodies  (1:2,000;
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using  a  chemiluminescent  reagent  (Amersham  ECL  Plus
western  blotting  detection  system;  General  Electric,
Buckinghamshire, UK). Blots were then exposed to X-ray
film (Thermo Scientific, Rockford, IL). Western blot analyses
were  performed  in  both  biologic  and  technical  triplicate.
FMR1 (fragile X mental retardation syndrome 1 homolog)
was used as a loading control, as previously described [6].
Analysis  of  Dstncorn1/Dstn+  relative  density  ratio:  The
Dstncorn1 relative density/Dstn+ relative density measurements
were  performed  via  scanning  densitometry  using  ImageJ
software. Bands identified as SRF were normalized against
their  respective  FMR1  control  bands.  Normalized  values,
obtained in biologic triplicate, were then pooled for analysis.
Histological  quantification  of  proliferating  cells  and
inflammatory cells: Corneal frozen sections were stained for
the  proliferation  marker  Ki67,  the  pan-leukocyte  marker
CD45, the neutrophil marker myeloperoxidase (MP), and the
nuclear  marker  DAPI.  Cells  were  counted  using  ImageJ
software  on  digital  images  taken  using  the  SPOT  Image
Analysis system. Two separate, nonconsecutive sections were
analyzed for each eye for each phenotype.
Quantification of the vascularized area of the cornea: Digital
images of all corneal flat mounts were collected using the Spot
Image Analysis system. Vascularized area and total corneal
area were measured using ImageJ software with a method
similar to that of Bock et al. [7]. Briefly, filters were applied
to subtract background, reduce noise, and enhance contrast.
The total corneal area was outlined using the innermost vessel
of the limbal arcade as the border, and the area of CD31-
positive vessels within the cornea was then calculated and
normalized  to  the  total  corneal  area  (expressed  as  the
percentage  of  vascularized  cornea)  using  thresh  holding
analysis. Filters were applied to subtract background, reduce
noise,  and  enhance  contrast.  The  total  corneal  area  was
outlined using the innermost vessel of the limbal arcade as the
border,  and  the  area  of  CD31-positive  vessels  within  the
cornea was then calculated and normalized to the total corneal
area (expressed as the percentage of vascularized cornea)
using threshholding analysis.
Statistical analysis: For comparison of three groups, a one-
way ANOVA was performed, followed by pairwise t-tests
with a Bonferroni correction if the ANOVA resulted in a
p<0.05. For comparison of two groups, a two-tailed, unpaired
t-test was used. GraphPad Prism software (GraphPad, San
Diego, CA) was used for statistical analysis and to create all
graphs  reporting  numerical  values.  *p<0.05,  **p<0.01,
***p<0.001.
RESULTS
Characterization of genetic mutations in the gene for DSTN
and phenotypic differences in the cornea of A.BY Dstncorn1
and B6 Dstncorn1–2J had been reported previously [1,3,5]. In this
study,  we  created  the  congenic  lines  B6.Cg-Dstncorn1  and
A.BY.Cg-Dstncorn1–2J  to  compare  to  the  original  lines.
Dstncorn1 mice lack the coding region for DSTN and represent
a null mutant of the Dstn protein, while Dstncorn1–2J mice are
characterized by a non-synonymous mutation in the actin
binding  domain  of  DSTN  that  most  likely  results  in
hypomorphic activity.
Even  upon  gross  visual  analysis,  these  two  Dstn
mutations exhibit phenotypic differences at P58 (Figure 1).
The corneal surface of A.BY Dstncorn1 and B6.Cg-Dstncorn1
mice  is  roughened  and  blood  vessels  are  clearly  visible.
Cataracts  in  the  lens  are  another  characteristic  feature  of
Dstncorn1 eyes in both backgrounds at P58. The corneal surface
of A.BY.Cg-Dstncorn1–2J and B6 Dstncorn1–2J also appears rough
when compared to WT, but to a lesser degree. In mice with
the Dstncorn1–2J mutation, a cataract has not fully formed by P58
but  develops  in  all  mice  as  they  age  (data  not  shown).
Additionally,  neither  Dstncorn1-2J  mutant  displays  corneal
neovascularization (Figure 1).
By staining the whole mount cornea and frozen sections
of the cornea with phalloidin, which specifically binds to F-
actin, we compared F-actin accumulation among the four lines
of mice to WT. We observed that, even when comparing the
mutations  in  the  same  background  (A.BY  Dstncorn1vs
A.BY.Cg-Dstncorn1–2J and B6.Cg-Dstncorn1 versus B6 Dstncorn1–
2J), Dstncorn1–2J displays milder F-actin accumulation compared
to Dstncorn1 . The level of F-actin accumulation in the B6.Cg-
Dstncorn1  cornea  is  less  severe  compared  to  the  A.BY
Dstncorn1cornea (Figure 2).
To examine the amount of corneal neovascularization, we
performed immunofluorescence using an anti-CD31 antibody
on whole cornea. Quantification of the vascularized area in
A.BY Dstncorn1 to A.BY.Cg-Dstncorn1–2J and B6.Cg-Dstncorn1 to
B6 Dstncorn1–2J and WT mice revealed that significant corneal
neovascularization  occurs  only  in  mice  with  the  Dstncorn1
mutation, in both the A.BY and B6 backgrounds. There is no
significant difference in the amount of vasculature in Dstncorn1–
2J  compared  to  WT  (Figure  3A,B).  Neovascularization  is
significantly reduced in the cornea of B6.Cg-Dstncorn1 mice
compared to A.BY Dstncorn1 mice. While this difference is
apparent and significant by P28, the difference increases in
significance with age (Figure 3C).
To detect proliferating cells in the corneal epithelium, we
performed  immunohistochemistry  using  an  anti-Ki67
antibody. We compared the amount of proliferation in each of
the four lines and found that the number of proliferating cells
in the corneal epithelia of Dstncorn1 mice is significantly more
than that in the corneal epithelia of Dstncorn1–2J mice in both
the  A.BY  and  B6  backgrounds  (Figure  4A,B).
Hyperproliferation was significantly increased in the corneal
epithelia  of  A.BY  Dstncorn1  mice  compared  to  B6.Cg-
Dstncorn1  mice  (Figure  4C).  The  trend  of  increased
hyperproliferation  in  the  corneal  epithelium  of  A.BY
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becomes significant by P58 (Figure 4C). In contrast, when
comparing  these  phenotypes  between  A.BY.Cg-Dstncorn1–2J
and B6 Dstncorn1–2J mice, we did not observe any significant
difference.
To detect inflammatory cells in the corneal epithelium,
we performed immunohistochemistry using anti-CD45 and
anti-myeloperoxidase antibodies. We compared the amount
of inflammation in the cornea of mice from each of the four
lines.  We  found  that  there  is  significantly  increased
recruitment of inflammatory cells to the cornea of Dstncorn1
mice  when  compared  to  Dstncorn1–2J  or  WT  mice,  an
observation common to both backgrounds. There is also a
significant  increase  in  inflammatory  cells  in  Dstncorn1–2J
mutant corneas compared to WT (Figure 5A,B). The level of
inflammation was significantly increased in the cornea of
A.BY  Dstncorn1  mice  compared  to  B6.Cg-Dstncorn1  mice
(Figure 5C). In the corneal epithelium of Dstncorn1 mice, the
trend of increased inflammation in the A.BY compared to the
B6 background is seen at P28 and becomes significant by P58
(Figure 5C). In contrast, when comparing these phenotypes
between A.BY.Cg-Dstncorn1–2J and B6 Dstncorn1–2J mice, we did
not observe any significant difference.
We  had  previously  identified  the  transcription  factor
serum  response  factor  (SRF)  as  a  major  contributor  to
Dstncorn1 phenotypes [2,6]. To assess the quantity of SRF in
the  Dstncorn1  mutants  in  both  genetic  backgrounds,  we
performed western blot analysis. We found that the level of
SRF  is  higher  in  Dstncorn1  when  compared  WT  in  both
backgrounds (Figure 6A). Additionally, statistical analysis
reveals  that  the  level  of  induction  of  SRF  expression  in
Dstncorn1 mutants, that is, the increase relative to WT, is not
significantly different between genetic backgrounds. (Figure
6B).
Our results suggest that phenotypic differences between
Dstn  mutants  are  due  to  allelic  differences.  Actin
accumulation,  neovascularization,  proliferation  and
inflammatory  response  differences  between  Dstncorn1  and
Dstncorn1–2J remain consistent when compared in two genetic
backgrounds.  Notably,  phenotypes  caused  by  the
Dstncorn1mutation are also modified by genetic background. In
every case, the abnormal phenotype is dampened in the cornea
Figure 1. Gross anatomic imaging of eyes of A.BY Dstncorn1, B6.Cg-Dstncorn1 , A.BY.Cg-Dstncorn1–2J, B6 Dstncorn1–2J, A.BY WT, and B6 WT
mice. Corneal neovascularization occurs only in lines with the Dstncorn1mutation (arrowheads in B6.Cg-Dstncorn1). While all Dstn mutants
display a roughened corneal surface, this phenotype is more severe in Dstncorn1. Cataract formation occurs in all four mutants, but is delayed
in Dstncorn1–2J when compared to Dstncorn1.
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609Figure 2. F-actin in the cornea of Dstn mutants and WT mice in both the A.BY and B6 background at P58. A: Phalloidin staining of whole
mount cornea at P58 shows that F-actin (red) accumulation more severe in Dstncorn1 cornea compared to Dstncorn1–2J cornea in both the A.BY
and B6 background. F-actin accumulation is less severe in the cornea of B6.Cg-Dstncorn1 when compared to A.BY Dstncorn1 . Bar, 200 μm.
B: Phalloidin staining of frozen sections illustrates the degree of F-actin (gray in upper panels, red in lower panels) accumulation in each
Dstn mutant compared to WT. Two portions of an A.BY Dstncorn1 cornea are shown to represent its irregular surface. Bar, 20 μm. All slides
were counterstained with DAPI to mark cell nuclei (blue).
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crossed  the  Dstncorn1  mutants  and  found  that  F1  mice
demonstrate a level of neovascularization that is intermediate
to and significantly different from A.BY Dstncorn1 and B6.Cg-
Figure 3. Corneal neovascularization caused by the Dstncorn1 mutation. A: Immunofluorescence for CD31 highlights blood vessels that infiltrate
Dstncorn1 cornea in both the A.BY and B6 background. Significant neovascularization is not observed as a result of the Dstncorn1–2J mutation,
making the appearance similar to WT. Bar, 200 μm. B: Quantification of the vascularized area shows that Dstncorn1 cornea have significantly
more vasculature compared to Dstncorn1–2J and WT cornea in both genetic backgrounds (p<0.001 for both backgrounds). Note that the resting
level of vasculature is higher in B6 than A.BY. C: Genetic background effect on the neovascularization phenotype in the Dstncorn1 cornea is
significant at postnatal day 28, and becomes even more significant with age. Sample sizes: A.BY.Cg-Dstncorn1–2J P58 n=5, A.BY Dstncorn1
P58 n=11, A.BY WT P58 n=3, B6 Dstncorn1–2J P58 n=4, B6.Cg-Dstncorn1 P58 n=10, B6 WT P58 n=4, A.BY Dstncorn1 P28 n=11, B6.Cg-
Dstncorn1 P28 n=6. Error bars, SEM * denotes statistical significance resulting from t-tests, with omitted bars representing nonsignficance.
*p<0.05, **p<0.01, ***p<0.001.
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611Dstncorn1 (Figure 7A,B). These results suggest the presence of
a genetic factor that is variable between B6 and A.BY and
affects the phenotype in a dosage-dependent manner.
DISCUSSION
Dstncorn1 and Dstncorn1–2J contribute to observed phenotypic
differences: By observing corneal phenotypes on the same
genetic background, this study shows that the differences in
Figure 4. Epithelial hyperproliferation in Dstncorn1 corneas. A: Immunofluorescence for Ki67 (green) labels proliferating cells in the corneal
epithelium of Dstn mutants and WT mice on A.BY and B6 backgrounds at P58. All slides were counterstained with DAPI to mark cell nuclei
(blue), which is shown merged with Ki67 staining in the lower panels. Bar, 20 μm. B: Quantification of Ki67 positive cells shows significantly
increased numbers of proliferating cells in Dstncorn1 cornea compared to Dstncorn1–2J and WT cornea in both A.BY and B6 backgrounds at P58
(p<0.001 for both backgrounds). C: A tendency for increased hyperproliferation in A.BY Dstncorn1 compared to B6.Cg-Dstncorn1 is observed
by P28. This difference becomes statistically significant by P58. Sample sizes: A.BY.Cg-Dstncorn1–2J P58 n=4, A.BY Dstncorn1 P58 n=5, A.BY
WT P58 n=4, B6 Dstncorn1–2J P58 n=3, B6.Cg-Dstncorn1 P58 n=5, B6 WT P58 n=4, A.BY Dstncorn1 P28 n=6, B6.Cg-Dstncorn1 P28 n=3. Unit
length=300 μm. Error bars, SEM * denotes statistical significance resulting from t-tests, with omitted bars representing non-significance.
*p<0.05, **p<0.01, ***p<0.001.
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612abnormal phenotypes that we observe in Dstn mutant mice are
due to the allelic difference between Dstncorn1 and Dstncorn1–
2J . These observations are consistent with our previous finding
that Dstncorn1 is a null mutation, while Dstncorn1–2J is a point
mutation [3]. Since the point mutation in Dstncorn1–2J leads to
an amino acid change in the actin binding region of DSTN,
the protein resulting from the Dstncorn1–2J mutation likely has
residual  functions  leading  to  the  milder  phenotypes  in
Dstncorn1–2J  cornea  compared  to  Dstncorn1  cornea  where  no
DSTN protein is produced.
Genetic modification is specific to the Dstncorn1 mutation: The
cornea of B6.Cg-Dstncorn1 mice display milder forms of each
phenotype  when  compared  to  A.BY  Dstncorn1  .  This
modification is not seen when comparing the cornea of B6
Dstncorn1–2J to A.BY.Cg-Dstncorn1–2J, suggesting the existence
of genetic modifiers that specifically interact with molecules
or pathways affected by the Dstncorn1 mutation. In fact, our
previous microarray study to compare A.BY Dstncorn1 and B6
Dstncorn1–2J  to  their  WT  counterparts  revealed  that  the
Dstncorn1  mutation  led  to  differential  expression  of  1,226
annotated  genes,  whereas  the  Dstncorn1–2J  mutation  led  to
changes in only 202 annotated genes [2]. Based on these
observations, we speculate that the modifier or modifiers may
belong  to  or  interact  with  the  set  of  ~1000  genes  whose
differential  expression  is  observed  in  Dstncorn1  and  not  in
Dstncorn1–2J . Another possible reason which could explain
genetic modification specific to the Dstncorn1 mutation is the
involvement  of  a  compensating  mechanism  that  may  be
activated by a complete loss of destrin (Dstncorn1) but not by a
point mutation (Dstncorn1–2J). There are 2 other members of the
Figure 5. Recruitment of inflammatory cells to the cornea of Dstn mutants. A: Immunofluorescence using CD45 (red) to mark inflammatory
cells and myeloperoxidase to mark neutrophils specifically in Dstn mutant and WT cornea on A.BY and B6 backgrounds at P58. All slides
were counterstained with DAPI to mark cell nuclei (blue). Bar, 20 μm. B: Quantification of CD45 positive cells revealed significantly increased
inflammation in both Dstncorn1 and Dstncorn1–2J mutant cornea compared to WT at P58 (p<0.001 for both backgrounds). C: The trend for
increased inflammation in A.BY Dstncorn1 compared to B6.Cg-Dstncorn1 is present by P28 and increases to significance by P58. Sample sizes:
A.BY.Cg-Dstncorn1-2J P58 n=4, A.BY Dstncorn1 P58 n=8, A.BY WT P58 n=4, B6 Dstncorn1–2J P58 n=4, B6.Cg-Dstncorn1 P58 n=6, B6 WT P58
n=4, A.BY Dstncorn1 P28 n=6, B6.Cg-Dstncorn1 P28 n=3. Unit length=300 um. Error bars, SEM * denotes statistical significance resulting from
t-tests, with omitted bars representing non-significance. *p<0.05, **p<0.01, ***p<0.001.
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613actin depolymerizing factor family in mice, cofilin 1 which is
ubiquitously expressed and cofilin 2 which is muscle specific
[8]. We previously observed upregulation of cofilins in the
A.BY  Dstncorn1cornea,  indicating  the  existence  of  the
compensating mechanism by cofilins [3]. It is possible that
compensation  by  cofilins  is  more  effective  in  the  B6
background compared to the A.BY background, leading to
milder phenotypes in the B6.Cg-Dstncorn1 cornea compared to
the A.BY Dstncorn1cornea.
Effects of genetic variation on the mouse cornea: Genetic
background  effects  have  been  observed  for  various
phenotypes in the mouse cornea. The rate of wound healing,
along with epithelial migration, was found to be greater in the
cornea of B6 mice compared to BALB/c mice [9]. Induced
corneal  neovascularization  [10,11]  as  well  as
lymphangiogenesis [12,13] has also been shown to be greatly
affected by the genetic background. Central corneal thickness,
which is known to be associated with the risk for glaucoma,
differs among inbred strains of mice [14] and quantitative trait
locus  (QTL)  analysis  identified  a  genetic  locus  that  is
significantly associated with this phenotype [15]. Our data
demonstrates that genetic background has a significant effect
on the severity of Dstncorn1 phenotypes, indicating the presence
of a QTL that interacts with this mutation. We subsequently
found  that  the  F1  neovascularization  phenotype  is
intermediate to both Dstncorn1 mutants, suggesting that the
locus or loci may act in a semi-dominant manner. Future
identification  of  genetic  factors  responsible  for  these
phenotypic differences in the cornea of Dstncorn1 mice should
provide  valuable  information  regarding  the  molecular
networks that regulate homeostasis and pathogenesis in the
cornea.
The  genetic  modifier  of  Dstncorn1  acts  in  a  pathway
independent of SRF: Notably, all known phenotypes caused
by the Dstncorn1 mutation are similarly affected by genetic
background. This observation suggests that genetic factors
responsible for these phenotypic differences act on the part of
a molecular pathway that affects all of these phenotypes. We
previously identified one transcription factor that appears to
be  responsible  for  all  phenotypes  caused  by  the  Dstncorn1
mutation. Gene expression analysis revealed that multiple
molecules  that  are  downstream  of  the  transcription  factor
SRF, as well as SRF itself, are abnormally upregulated in the
cornea of Dstncorn1 mice [2]. Inactivation of SRF specifically
in the corneal epithelium of the Dstncorn1 mice rescued all
phenotypes caused by this mutation [6]. Data from this study
suggest that the level of induction of SRF in Dstncorn1 mutants
does not appear to be directly responsible for the variation in
severity  of  the  phenotypes.  That  is,  since  the  levels  of
induction of SRF in A.BY Dstncorn1 and B6.Cg-Dstncorn1 are
not significantly different, we conclude that there exists an
additional  regulator  responsible  for  the  dampening  of
phenotypes  in  the  B6  background.  Since  genetic  factors
responsible  for  phenotypic  differences  between  A.BY
Dstncorn1 and B6.Cg-Dstncorn1 mice affect all phenotypes in a
similar manner, we hypothesize that these genetic factors may
act downstream from SRF in a molecular pathway, or else
function in an independent manner. Further investigation of
the SRF pathway along with identification of these genetic
factors will test this possibility.
Conclusions:  This  study  has  shown  that  phenotypic
differences between the Dstn mutants Dstncorn1 and Dstncorn1–
2J are due to allelic differences. Additionally, further analysis
revealed that phenotypes caused by the Dstncorn1 mutation are
Figure 6. Western blot analysis for SRF in Dstncorn1 mutant and WT cornea. A: SRF level is greater in Dstncorn1 mutant cornea compared to
WT. B: When comparing the induction of SRF expression by the Dstncorn1 mutation (SRF increase in Dstncorn1 with respect to WT) in both
the A.BY and B6 background, there is no significant difference in the increase of SRF between these genetic backgrounds. Error bars, SEM
* denotes statistical significance resulting from t-tests. *p<0.05, **p<0.01, ***p<0.001, ns=nonsignificant.
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614modified  by  genetic  background.  Our  work  indicates  that
there  are  additional  factors  that  regulate  the  Dstncorn1
phenotypes other than SRF, which was previously determined
as a major contributor. Further identification of factors that
play  a  role  in  the  formation  of  Dstncorn1  phenotypes  will
provide  valuable  insights  into  the  regulation  of  actin
dynamics,  absence  of  vasculature,  controlled  epithelial
proliferation and inflammatory response in the cornea.
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